RxDoctor Payments Data

Christopher Cannova, MD

Orthopedic Surgery · Bethesda, MDNPI 1235134560

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $1,187,312 of the $1,586,595 with a category attached, or 74.8%. Zimmer Biomet accounts for 98.8% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $428,685, 4.7 times the $91,745 reported in 2019. Among orthopedic surgery clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,586,595in general payments, 2019–2025

Across 600 payments — averaging $2644.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$1.6M
  • Stryker$11K
  • Smith+Nephew$7K
  • Conformis, Inc.$400
  • Medtronic$223
  • Medacta USA, Inc.$115
  • plus $338 from 6 others
$57,103in research payments, 2019–2025

Across 42 payments — averaging $1359.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$57K

What the payments were for

  • Royalty or licence$1,187,31275%
  • Consulting fees$311,20020%
  • Speaking & faculty fees$4000%
  • Travel & lodging$57,9024%
  • Food & beverage$9,2821%
  • Education$20,5001%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,586,595 in reported general payments places this provider in the 95th percentile of 24 orthopedic surgery providers in Maryland.

See all orthopedic surgery providers in Maryland

Medicare billing

Part B allowed, 2024
$1,230,346
Medicare patients
1,597
Services billed
8,479

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib128$4,327
Tramadol Hcl192$489
Oxycodone Hcl116$448
Diclofenac Sodium32$302
Amoxicillin90$197
Meloxicam51$194
Pantoprazole Sodium28$191
Cephalexin38$136
Mupirocin16$109
Methylprednisolone11$103
Clindamycin Hcl36$85
Cyclobenzaprine Hcl16$67

Paid to pharmacies, not to this prescriber.

Other orthopedic surgery in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →